At the Leukemia & Lymphoma Society (LLS), advocacy is in our blood. We are a vibrant community of researchers, volunteers, philanthropists, advocates, healthcare professionals, and nonprofit leaders.
Each day, we fight to find cures for blood cancers and help every patient access the care they need to survive and thrive. We believe our individual backgrounds, identities, abilities, and experiences are our greatest sources of creativity and innovation as we work together to create a more equitable world without blood cancer.
We stand for equal treatment, equal opportunities, and equal rights for Black, Indigenous, and People of Color (BIPOC), people with disabilities, Hispanics and Latino/a/x, members of the LGBTQIA+ community, veterans, women, and other underrepresented groups.
Together, we are working tirelessly to create pathways for equity for our staff, our volunteers, and our communities, while driving forward change that honors our mission and stands against systemic racism and injustice in all its forms. We are determined to break down barriers and address the needs of underserved populations. To date, we have pioneered advances in treatment that stem from a diverse ecosystem. By bringing together different perspectives, backgrounds, and thinking, we are fueling innovative breakthroughs that are a life force for blood cancer patients and their families who deserve to receive the best care and support possible.
At LLS, it is important that our teams reflect the communities we serve. We are dedicated to fostering an inclusive workplace where everyone feels welcome, seen, and heard. We grow stronger when we embrace and learn from our differences. At the same time, we recognize that our shared identities unite us, creating a sense of belonging.
We believe in continuous improvement, and we know we have more to do. As the global leader in the fight to end blood cancers, finding cures for all people impacted by these diseases is in our DNA. We will continue to educate ourselves, engage in difficult conversations, and hold ourselves and each other accountable.
Because curing blood cancer needs every one of us. Join us today.
CHAMPIONING DIVERSITY, EQUITY, & INCLUSION AT LLS
DRIVING EQUITABLE ACCESS TO CARE THROUGH OUR MISSION
LLS is dedicated to addressing gaps in cancer outcomes and healthcare that disproportionately impact minority and rural communities and other underserved populations. Learn how our multifaceted efforts across research, education and support, and advocacy are breaking down barriers to care. With your help, we want to do even more.
2021 LLS Patient Support Impact Report
See our new and ongoing efforts to advance health equity, reduce out-of-pocket costs, and so much more.
The incidence of myeloma is twice as high among Black Americans as among white Americans, and Black patients are less likely to have access to timely, optimal treatment and care. Carried out by staff and volunteers in 13 Black communities across the country, Myeloma Link directly connects community members to free myeloma information and support, as well as treatment and care.
Our Office of Public Policy in Washington, D.C., along with 30,000 online advocates, is leaving no stone unturned in the fight for equity in healthcare. From taking action against the staggering cost of cancer care to advancing The 100 Days Agenda: A Patient-First Blueprint to ensure quality, affordable care for all Americans, we’re driving change at the federal and state level.
LLS Information Specialists – highly trained oncology professionals – provide free, one-on-one support and guide patients and caregivers to our wide array of free education and support services that can help. We offer in-depth clinical trial navigation, translation services, a Spanish-language website with resources, bilingual (English/Spanish) Information Specialists, and more.
At LLS, we believe no one should have to choose between affording groceries or their cancer treatments. Our robust financial assistance programs help blood cancer patients and families with non-medical expenses, travel-related costs, and co-pays.